Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
dc.contributor.author | Powles, Thomas | |
dc.contributor.author | Kockx, Mark | |
dc.contributor.author | Rodriguez-Vida, Alejo | |
dc.contributor.author | Duran, Ignacio | |
dc.contributor.author | Crabb, Simon J | |
dc.contributor.author | Van Der Heijden, Michiel S | |
dc.contributor.author | Szabados, Bernadett | |
dc.contributor.author | Pous, Albert Font | |
dc.contributor.author | Gravis, Gwenaelle | |
dc.contributor.author | Herranz, Urbano Anido | |
dc.contributor.author | Protheroe, Andrew | |
dc.contributor.author | Ravaud, Alain | |
dc.contributor.author | Maillet, Denis | |
dc.contributor.author | Mendez, Maria Jose | |
dc.contributor.author | Suarez, Cristina | |
dc.contributor.author | Linch, Mark | |
dc.contributor.author | Prendergast, Aaron | |
dc.contributor.author | van Dam, Pieter-Jan | |
dc.contributor.author | Stanoeva, Diana | |
dc.contributor.author | Daelemans, Sofie | |
dc.contributor.author | Mariathasan, Sanjeev | |
dc.contributor.author | Tea, Joy S | |
dc.contributor.author | Mousa, Kelly | |
dc.contributor.author | Banchereau, Romain | |
dc.contributor.author | Castellano, Daniel | |
dc.date.accessioned | 2025-01-07T13:16:42Z | |
dc.date.available | 2025-01-07T13:16:42Z | |
dc.date.issued | 2020 | |
dc.description.abstract | An amendment to this paper has been published and can be accessed via a link at the top of the paper. | |
dc.identifier.doi | 10.1038/s41591-020-0923-3 | |
dc.identifier.essn | 1546-170X | |
dc.identifier.pmid | 32555515 | |
dc.identifier.unpaywallURL | https://www.nature.com/articles/s41591-020-0923-3.pdf | |
dc.identifier.uri | https://hdl.handle.net/10668/25386 | |
dc.issue.number | 6 | |
dc.journal.title | Nature medicine | |
dc.journal.titleabbreviation | Nat Med | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario Reina Sofía | |
dc.page.number | 983 | |
dc.pubmedtype | Journal Article | |
dc.pubmedtype | Published Erratum | |
dc.rights.accessRights | open access | |
dc.title | Publisher Correction: Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 26 |